赛诺菲安万特(SNY)

47.23+0.10+0.21%

社区社区
资讯资讯
资料资料
公告公告

- 最新
- 推荐
- 辉瑞、赛诺菲押注！AI制药估值10亿美元，22款药物进入临床！
  智药局 · 04-16
  辉瑞、赛诺菲押注！AI制药估值10亿美元，22款药物进入临床！
- 财报前瞻｜赛诺菲安万特本季度营收预计增10.21%，机构观点偏正面
  财报Agent · 04-16
  财报前瞻｜赛诺菲安万特本季度营收预计增10.21%，机构观点偏正面
- 还没进临床，就融了10亿：华人创立眼科biotech为何屡获巨头押注？
  药融圈 · 03-12
  还没进临床，就融了10亿：华人创立眼科biotech为何屡获巨头押注？
- 赛诺菲换帅，任命默克KGaA首席执行官为下一任CEO
  环球市场播报 · 02-13
  赛诺菲换帅，任命默克KGaA首席执行官为下一任CEO
- 65岁西班牙人成为赛诺菲史上首位女CEO，为何股价下跌
  第一财经 · 02-13
  65岁西班牙人成为赛诺菲史上首位女CEO，为何股价下跌
- 研发失速叠加特朗普变量赛诺菲(SNY.US)新CEO加里霍面临双重挑战
  智通财经 · 02-13
  研发失速叠加特朗普变量赛诺菲(SNY.US)新CEO加里霍面临双重挑战
- 赛诺菲(SNY.US)突发换帅：研发“哑火”成“催命符”，默沙东高管火线接手
  智通财经 · 02-12
  赛诺菲(SNY.US)突发换帅：研发“哑火”成“催命符”，默沙东高管火线接手
- 明星药物Dupixent销售额再创新高！赛诺菲(SNY.US)Q4盈利超预期
  智通财经 · 01-29
  明星药物Dupixent销售额再创新高！赛诺菲(SNY.US)Q4盈利超预期
- 财报前瞻｜赛诺菲安万特本季度营收预计增17.09%，机构观点偏正面
  财报Agent · 01-22
  财报前瞻｜赛诺菲安万特本季度营收预计增17.09%，机构观点偏正面
- 独家：FDA推迟赛诺菲糖尿病药物Tzield与Disc Medicine血液疾病药物审评时间表 - 文件披露
  美股速递 · 01-15
  独家：FDA推迟赛诺菲糖尿病药物Tzield与Disc Medicine血液疾病药物审评时间表 - 文件披露
- Anthropic与赛诺菲(SNY)、诺和诺德(NVO)等生物制药公司合作进军医疗保健人工智能领域
  金吾财讯 · 01-14
  Anthropic与赛诺菲(SNY)、诺和诺德(NVO)等生物制药公司合作进军医疗保健人工智能领域
- 赛诺菲安万特(SNY)盘前升0.5% 普乐司兰钠注射液在华获批
  金吾财讯 · 01-06
  赛诺菲安万特(SNY)盘前升0.5% 普乐司兰钠注射液在华获批
- 12月24日美股盘前要闻
  钛媒体快报 · 2025-12-24
  12月24日美股盘前要闻
- 赛诺菲以每股15.50美元的现金价格收购Dynavax所有流通股
  老虎资讯综合 · 2025-12-24
  赛诺菲以每股15.50美元的现金价格收购Dynavax所有流通股
- 默沙东(MRK.US)、施贵宝(BMY.US)等多家药企同意下调美国药价以换取特朗普政府关税豁免和政策支持
  智通财经 · 2025-12-20
  默沙东(MRK.US)、施贵宝(BMY.US)等多家药企同意下调美国药价以换取特朗普政府关税豁免和政策支持
- 美国官员称与安进、施贵宝、罗氏旗下基因泰克、吉利德、葛兰素史克、默沙东、诺华、赛诺菲和博瑞诺的交易
  美股速递 · 2025-12-20
  美国官员称与安进、施贵宝、罗氏旗下基因泰克、吉利德、葛兰素史克、默沙东、诺华、赛诺菲和博瑞诺的交易
- 创新药研发充满荆棘，近期多家药企接连宣布“折戟”
  制药网 · 2025-12-18
  创新药研发充满荆棘，近期多家药企接连宣布“折戟”
- 赛诺菲(SNY.US)宣布第二代心肌肌球蛋白抑制剂在华获批上市
  智通财经 · 2025-12-17
  赛诺菲(SNY.US)宣布第二代心肌肌球蛋白抑制剂在华获批上市
- 1天两笔交易，超26亿美元！制药巨头抢滩自免赛道
  医药魔方 · 2025-12-16
  1天两笔交易，超26亿美元！制药巨头抢滩自免赛道
- FDA延期叠加试验失败，赛诺菲多发性硬化症药物遭双重暴击
  智通财经 · 2025-12-15
  FDA延期叠加试验失败，赛诺菲多发性硬化症药物遭双重暴击
公司概况
公司名称
赛诺菲安万特
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.sanofi.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
Sanofi于1994年根据法国法律注册成立。该公司是一家全球领先的医疗保健公司，专注于患者需求并从事治疗解决方案的研究、开发、制造和营销。该公司的活动围绕以下类别组织：DUPIXENT、神经病学&免疫学、罕见病、肿瘤学、罕见血液病、普药核心资产和非核心资产、疫苗、CHC。
- 04-10
  超过5%披露
  Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
  Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
- 02-17
  员工持股计划
  Form S-8 - Securities to be offered to employees in employee benefit plans
  Form S-8 - Securities to be offered to employees in employee benefit plans
- 02-17
  年度报告
  Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
  Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
- 02-05
  员工持股计划
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2025-10-28
  [补充]招股说明书
  Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
  Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
- 2025-10-28
  [补充]招股说明书
  Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
  Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
- 2025-10-28
  [补充]招股说明书
  Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
  Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
- 2025-10-28
  [补充]招股说明书
  Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
  Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
- 2025-10-28
  [补充]招股说明书
  Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
  Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
- 2025-06-27
  员工持股计划
  Form 11-K - Annual report of employee stock purchase, savings and similar plans
  Form 11-K - Annual report of employee stock purchase, savings and similar plans
- 2025-06-27
  员工持股计划
  Form 11-K - Annual report of employee stock purchase, savings and similar plans
  Form 11-K - Annual report of employee stock purchase, savings and similar plans
- 2025-03-27
  员工持股计划
  Form S-8 - Securities to be offered to employees in employee benefit plans
  Form S-8 - Securities to be offered to employees in employee benefit plans
- 2025-03-21
  员工持股计划
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2025-02-13
  年度报告
  Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
  Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
- 2024-11-07
  超过5%披露
  Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
  Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

分时
5日
日
周
月

数据加载中...

最高

47.55

今开

47.53

量比

1.13

最低

47.13

昨收

47.13

换手率

0.04%

赛诺菲安万特(SNY)

公司概况

热议股票